Neuroscience
5-HT1A Receptor
5%
5-HT2C Receptor
20%
Adenylyl Cyclase
7%
Agonist
34%
Allodynia
8%
Amino Terminal Sequence
7%
Arachidonic Acid
17%
Bradykinin
37%
Brain
5%
Cell Signaling
8%
Dopamine
6%
Dopamine Release
6%
Eicosanoid Receptor
65%
Enkephalin
10%
Estrogens
10%
Extracellular Signal-Regulated Kinases
6%
Functional Selectivity
7%
In Vitro
10%
In Vivo
21%
Inositol Phosphate
8%
Inverse Agonism
5%
Inverse Agonist
10%
Kappa Opiate Receptor
10%
Kinase
7%
Ligand
22%
Neuron
12%
Nociceptor
9%
Norbinaltorphimine
7%
Opioid
8%
Phospholipase A2
6%
Phospholipase C
9%
Prostaglandin E2
5%
Protein Kinase C
10%
Receptor Agonists
8%
Receptor Subtype
6%
Sensory Neuron
22%
Serotonin
14%
Trigeminal Ganglion
9%
δ -Opioid Receptor
19%
Κ-opioid receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
13%
Adenylate Cyclase
11%
Agonist
32%
Antagonist
14%
Arachidonic Acid
22%
Bradykinin
28%
Calcium
5%
Chinese Hamster
6%
Delta Opiate Receptor
5%
Desensitization
15%
Dopamine
5%
Drug
11%
Drug Development
5%
Enkephalin
10%
Forskolin
5%
Functional Selectivity
9%
Heteromer
11%
Inositol Phosphate
10%
Inverse Agonist
10%
Ligand
26%
Naloxone
7%
Norbinaltorphimine
7%
Opiate Receptor
16%
Phospholipase A2
8%
Phospholipase C
6%
Phosphotransferase
5%
Prostaglandin E2
5%
Protein Kinase C
13%
Proteinase Activated Receptor 2
5%
Rat
15%
Receptor
100%
Receptor Subtype
7%
Serotonin
18%
Serotonin 2C Receptor
7%
Thermal Allodynia
7%
Medicine and Dentistry
Agonist
23%
Blood Transfusion
5%
Bradykinin
8%
Brain
5%
Cells
6%
Chemotherapeutic Agent
9%
Combination Therapy
5%
Dopamine
5%
Drug
9%
Ganglion
6%
In Vitro
7%
Inositol Phosphate
7%
Inverse Agonism
7%
Inverse Agonist
9%
Ligand
20%
Neuron
11%
Pain
6%
Patient
5%
Proteinase Activated Receptor 2
5%
Receptor
61%
Receptor Subtype
8%
Selectivity
9%
Signal Transduction
7%
Therapeutic Procedure
7%
κ-Opioid Receptor
5%
